- Home
- DEVS vs CELZ Comparison
DEVS vs CELZ Comparison
Compare DEVS & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DEVS
- CELZ
- Stock Information
- Founded
- DEVS N/A
- CELZ 1998
- Country
- DEVS Canada
- CELZ United States
- Employees
- DEVS N/A
- CELZ N/A
- Industry
- DEVS
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- DEVS
- CELZ Health Care
- Exchange
- DEVS NYSE
- CELZ Nasdaq
- Market Cap
- DEVS 6.4M
- CELZ 5.5M
- IPO Year
- DEVS N/A
- CELZ N/A
- Fundamental
- Price
- DEVS $0.21
- CELZ $1.97
- Analyst Decision
- DEVS
- CELZ
- Analyst Count
- DEVS 0
- CELZ 0
- Target Price
- DEVS N/A
- CELZ N/A
- AVG Volume (30 Days)
- DEVS 260.6K
- CELZ 96.9K
- Earning Date
- DEVS 05-12-2025
- CELZ 05-09-2025
- Dividend Yield
- DEVS N/A
- CELZ N/A
- EPS Growth
- DEVS N/A
- CELZ N/A
- EPS
- DEVS N/A
- CELZ N/A
- Revenue
- DEVS N/A
- CELZ $11,000.00
- Revenue This Year
- DEVS N/A
- CELZ N/A
- Revenue Next Year
- DEVS N/A
- CELZ N/A
- P/E Ratio
- DEVS N/A
- CELZ N/A
- Revenue Growth
- DEVS N/A
- CELZ 22.22
- 52 Week Low
- DEVS $0.18
- CELZ $1.69
- 52 Week High
- DEVS $1.91
- CELZ $6.90
- Technical
- Relative Strength Index (RSI)
- DEVS N/A
- CELZ 39.29
- Support Level
- DEVS N/A
- CELZ $1.90
- Resistance Level
- DEVS N/A
- CELZ $2.10
- Average True Range (ATR)
- DEVS 0.00
- CELZ 0.24
- MACD
- DEVS 0.00
- CELZ 0.06
- Stochastic Oscillator
- DEVS 0.00
- CELZ 37.84
About DEVS DEVVSTREAM CORP
DevvStream Corp is a technology-based ESG company that advances the development and monetization of environmental assets, with an initial focus on carbon markets. It works with governments and corporations to achieve its sustainability goals through the implementation of curated green technology projects that generate renewable energy, improve energy efficiencies, eliminate or reduce emissions, and sequester carbon directly from the air.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.